Document Detail

Seasonal variation of some metabolic and haemostatic risk factors in subjects with and without coronary artery disease.
MedLine Citation:
PMID:  11505078     Owner:  NLM     Status:  MEDLINE    
Acute myocardial infarction (AMI) is more frequent in winter months than in summer months. The aetiologic mechanisms underlying this seasonal pattern are poorly understood. We investigate whether seasonal variation of metabolic and haemostatic coronary risk factors exists, and whether this variation is more pronounced in subjects with coronary artery disease (CAD). In 82 subjects (47 free of clinical signs of CAD and in 35 survivors of AMI), measurements of body mass index (BMI), lipoproteins, glucose, insulin, plasminogen activator inhibitor-1, tissue-type plasminogen activator (t-PA), euglobulin clot lysis time, fibrinogen, and platelet count were performed twice in the cold months (December and March) and twice in the warm months (June and September). Significantly higher BMI (26.8 versus 26.2 kg/m2, P < 0.01), glucose (5.5 versus 5.1 mmol/l, P < 0.01), total cholesterol (5.61 versus 5.32 mmol/l, P < 0.05), low-density lipoprotein cholesterol (3.63 versus 3.34 mmol/l, P < 0.05), triglycerides (1.79 versus 1.61 mmol/l, P < 0.01), Lp(a) (270.7 versus 237.5 mg/l, P < 0.01), fibrinogen level (3.50 versus 2.95 g/l, P < 0.00001), platelet count (212 x 10(9) versus 173 x 10(9)/l, P < 0.01) and significantly lower high-density lipoprotein cholesterol level (1.22 versus 1.28 mmol/l, P < 0.05) were observed in the cold months compared with the warm months. Significant seasonal variation of t-PA activity (1.19 versus 0.87 IU/ml, P = 0.015) and t-PA antigen (8.5 versus 7.3 ng/ml, P = 0.05) was demonstrated only in subjects with CAD. Clustering of peak values of several metabolic and haemostatic coronary risk factors was observed in winter months. This variation might be of aetiopathogenetic importance for the seasonal pattern of acute myocardial infarction.
A Mavri; B Guzic-Salobir; B Salobir-Pajnic; I Keber; J Stare; M Stegnar
Related Documents :
12818418 - Autoantibodies against modified low-density lipoproteins in coronary artery disease.
17568588 - Plasma levels of granzyme b are increased in patients with lipid-rich carotid plaques a...
10769278 - Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by ...
9244208 - Functional evaluation of lipid-lowering therapy by pravastatin in the regression growth...
10545618 - Homocysteine and coronary heart disease: a review of the current evidence.
25231878 - Real time three-dimensional transesophageal echocardiography guided coronary sinus cann...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis     Volume:  12     ISSN:  0957-5235     ISO Abbreviation:  Blood Coagul. Fibrinolysis     Publication Date:  2001 Jul 
Date Detail:
Created Date:  2001-08-15     Completed Date:  2002-07-02     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9102551     Medline TA:  Blood Coagul Fibrinolysis     Country:  England    
Other Details:
Languages:  eng     Pagination:  359-65     Citation Subset:  IM    
Department of Angiology, University Medical Centre, Ljubljana, Slovenia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Blood Coagulation Factors / metabolism
Blood Glucose / analysis
Body Mass Index
Case-Control Studies
Coronary Artery Disease / blood,  epidemiology,  etiology*
Hemostatics / blood*
Lipids / blood
Middle Aged
Risk Factors
Reg. No./Substance:
0/Blood Coagulation Factors; 0/Blood Glucose; 0/Hemostatics; 0/Lipids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The effects of danaparoid, dalteparin and heparin on tissue factor-induced experimental disseminated...
Next Document:  Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphobl...